The separation and analysis of hepatitis B e antigen.

Area of Science:

• Virology
• Immunology
• Biochemistry

Background:

• Hepatitis B virus (HBV) infection is a significant global health concern.
• Hepatitis B e antigen (HBeAg) is a key marker in HBV infection, correlating with viral replication and infectivity.
• Understanding the physicochemical properties of HBeAg is crucial for developing diagnostic and therapeutic strategies.

Purpose of the Study:

• To develop and validate a solid-phase radioimmunoassay for detecting HBeAg in HBV-containing serum.
• To characterize the molecular properties of HBeAg, including molecular weight, isoelectric point, and polypeptide composition.
• To investigate the relationship between HBeAg properties and the immunopathogenesis of hepatitis B.

Main Methods:

• Solid-phase radioimmunoassay was employed for HBeAg detection.
• Ammonium sulfate precipitation and Sepharose CL-6B gel filtration were used for serum fractionation.
• Affinity chromatography on Blue Sepharose was utilized to assess antigen binding properties.

Main Results:

• The radioimmunoassay successfully detected HBeAg in fractionated HBV serum.
• Two HBeAg-containing fractions were isolated with molecular weights of 220,000 and 130,000.
• The smaller fraction (130,000 MW) had an isoelectric point of 4.9 and comprised polypeptides of 66,000 and 17,000 MW. HBeAg did not bind to Blue Sepharose under conditions that bound albumin.

Conclusions:

• The developed radioimmunoassay is effective for HBeAg detection.
• HBeAg exists in distinct molecular forms, providing insights into its structure.
• These findings contribute to understanding HBeAg's role in hepatitis B immunopathogenesis.